1. Home
  2. GRFS vs OLED Comparison

GRFS vs OLED Comparison

Compare GRFS & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.27

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

OLED

Universal Display Corporation

HOLD

Current Price

$97.04

Market Cap

4.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
OLED
Founded
1940
1985
Country
Spain
United States
Employees
25247
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.7B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
GRFS
OLED
Price
$8.27
$97.04
Analyst Decision
Hold
Buy
Analyst Count
2
2
Target Price
$10.15
$125.00
AVG Volume (30 Days)
573.0K
804.1K
Earning Date
07-28-2022
04-30-2026
Dividend Yield
1.80%
2.23%
EPS Growth
N/A
9.25
EPS
N/A
0.76
Revenue
N/A
$650,611,000.00
Revenue This Year
$4.49
$5.88
Revenue Next Year
$6.42
$10.36
P/E Ratio
$18.67
$127.12
Revenue Growth
N/A
0.45
52 Week Low
$7.08
$83.64
52 Week High
$11.14
$163.20

Technical Indicators

Market Signals
Indicator
GRFS
OLED
Relative Strength Index (RSI) 50.07 50.89
Support Level $7.64 $93.03
Resistance Level $8.88 $99.85
Average True Range (ATR) 0.18 3.74
MACD -0.02 -0.29
Stochastic Oscillator 38.54 71.89

Price Performance

Historical Comparison
GRFS
OLED

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. The large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: